Found: 14
Select item for more details and to access through your institution.
Cartografia, arte e potere tra Riforma e Controriforma: Il Palazzo Farnese a Caprarola.
- Published in:
- 2023
- By:
- Publication type:
- Book Review
Paintings on Stone: Science and the Sacred 1530–1800.
- Published in:
- 2023
- By:
- Publication type:
- Book Review
Earlier Diagnosis of ARVD/C With Novel Software.
- Published in:
- 2015
- By:
- Publication type:
- Product Review
Signaling prodromes of sudden cardiac death.
- Published in:
- Bosnian Journal of Basic Medical Sciences, 2013, v. 13, n. 1, p. 44, doi. 10.17305/bjbms.2013.2418
- By:
- Publication type:
- Article
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 3, p. 487, doi. 10.1007/s40744-024-00662-5
- By:
- Publication type:
- Article
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1255, doi. 10.1007/s40744-023-00576-8
- By:
- Publication type:
- Article
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 3, p. 839, doi. 10.1007/s40744-022-00439-8
- By:
- Publication type:
- Article
Electrocardiographic appearance of aortic stenosis before and after aortic valve replacement.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, p. 1, doi. 10.1177/1759720X221149965
- By:
- Publication type:
- Article
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2023, v. 15, p. 1, doi. 10.1177/1759720X221149965
- By:
- Publication type:
- Article
Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 3, p. 338, doi. 10.1093/ecco-jcc/jjac141
- By:
- Publication type:
- Article
Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52–92 data from a randomized, double-blind, phase 3 trial
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02626-4
- By:
- Publication type:
- Article
Izvješće o radu društva kemičara i tehnologa Osijek u razdoblju 26. 3. 2018. - 20. 9. 2019. godine.
- Published in:
- Kemija u Industriji, 2020, v. 69, n. 1/2, p. 71
- By:
- Publication type:
- Article